IHSN Survey Catalog
  • Home
  • Microdata Catalog
  • Citations
  • Login
    Login
    Home / Central Data Catalog / BFA_2017_HRBFIE-FEL_V01_M / variable [F9]
central

Results-Based Financing Impact Evaluation Health Facility 2017, Endline Survey

Burkina Faso, 2017
Get Microdata
Reference ID
BFA_2017_HRBFIE-FEL_v01_M
Producer(s)
Manuela de Allegri, Herve Hien, Paul Jacob Robyn
Metadata
DDI/XML JSON
Created on
Dec 05, 2019
Last modified
Dec 05, 2019
Page views
61775
Downloads
49
  • Study Description
  • Data Dictionary
  • Downloads
  • Get Microdata
  • Data files
  • f1_jul19
  • f1p_jul19
  • f1u_jul19
  • f2_jul19
  • f3_jul19
  • f4_jul19
  • f5_jul19
  • f6_jul19
  • f7_jul19

F7_219_M (f7_219_1)

Data file: f7_jul19

Overview

Valid: 224
Invalid: 0
Type: Discrete
Start: 510
End: 534
Width: 25
Range: -
Format: character

Questions and instructions

Categories
Value Category Cases
0 1
0.4%
00 21
9.4%
1 1
0.4%
3 2
0.9%
99 1
0.4%
A 1
0.4%
AMOXI 1
0.4%
AMOXI GELLULE 1
0.4%
AMOXI GELLULE 500MG 1
0.4%
ART LUM 1
0.4%
Albendazole 1
0.4%
Amoxi 500mg 1
0.4%
Amoxicilline 6
2.7%
Amoxicilline gellule 1
0.4%
Amoxycilline 1
0.4%
Artemether 2
0.9%
Artemether-lumefantrine 1
0.4%
AtL 1
0.4%
Butyl cp 1
0.4%
CEFTIAXONE 1
0.4%
COTRI 480MG 1
0.4%
COTRI CP 480MG 1
0.4%
Ciprofloxacine cp 1
0.4%
Cotri 480mg 1
0.4%
DEPOT PROVERA 1
0.4%
DICLOFENAC 1
0.4%
Depo Provera 1
0.4%
Depo provera 2
0.9%
Depoprovera 1
0.4%
Hydroxide 1
0.4%
Hydroxide d'aluminium 1
0.4%
Injectable SP 1
0.4%
Intranule 1
0.4%
Jadelle 4
1.8%
Lumartem cp 1
0.4%
MEO 2
0.9%
METO CP 1
0.4%
METRONIDAZOLE 1
0.4%
Metronidazole 250mg 1
0.4%
Norplant 2
0.9%
Nystatine 1
0.4%
Nystatine ovule 1
0.4%
PHLORO CP 1
0.4%
PHLOROGLUCINOL 1
0.4%
Paracetamol 5
2.2%
Paracetamol cp 2
0.9%
Phloroglucinol 1
0.4%
Phloroglucinol cp 1
0.4%
Ploroglucinol 1
0.4%
QUININE 300MG 1
0.4%
Quinine 3
1.3%
Quinine 300mg 3
1.3%
VAT 1
0.4%
VAT 1 DOSE 1
0.4%
VITA C 1
0.4%
Vitamine A 1
0.4%
albendazole 1
0.4%
albendazolz 1
0.4%
amixiciline 1
0.4%
amoxi 2
0.9%
amoxi gellule 1
0.4%
amoxiciline 4
1.8%
amoxicilline 2
0.9%
amoxicilline comp 2
0.9%
amoxicilline gel 1
0.4%
amoxicilline gel 500mg 1
0.4%
amoxicilline gelules 1
0.4%
amoxicilline sirop 1
0.4%
amoxycilline 1
0.4%
art lum 1
0.4%
artemether 1
0.4%
artemether lumartem 1
0.4%
artesunate amodiaquine 2
0.9%
artesunate cp 1
0.4%
artesunate et amodiaquine 1
0.4%
arthemeter 1
0.4%
arthemeter lumef antrine 1
0.4%
atemeter lumefantrine 1
0.4%
butul comprime 1
0.4%
chlor 1
0.4%
chlorphenamine 1
0.4%
chlorpheniramine 1
0.4%
chlorpheramine 1
0.4%
ciprofloxacin 1
0.4%
coartem 1
0.4%
cotri 1
0.4%
depot provera 1
0.4%
diclo 2
0.9%
diclo fenac 1
0.4%
diclo inj 1
0.4%
digoxine 1
0.4%
ery 500 1
0.4%
erythromicine 1
0.4%
erythromycine 1
0.4%
erytromicine 2
0.9%
etythromycine 1
0.4%
furosemide 1
0.4%
furosomyde injectable 1
0.4%
gant 1
0.4%
hydro 1
0.4%
hydroxicine d aluminum 1
0.4%
hyoscine butylbromide 1
0.4%
ibuprofane 1
0.4%
ibuprofen 1
0.4%
jadel 2
0.9%
mebendazole 2
0.9%
metro 1
0.4%
metrochloropramide 1
0.4%
miconazole pommade 1
0.4%
multi 1
0.4%
nifidipine 1
0.4%
novartis 1
0.4%
nystatine 1
0.4%
omeprazole gelules 1
0.4%
oo 1
0.4%
para 5
2.2%
para cp 3
1.3%
paracetamol 12
5.4%
paracetamol 500mg 1
0.4%
paracetamol comp 2
0.9%
phloro 2
0.9%
phloro cp 1
0.4%
phloroglicenol 1
0.4%
phloroglicinol 1
0.4%
phloroglucinol 10
4.5%
phloroglucinol inj 1
0.4%
phloroglucinole inj 1
0.4%
phloroglucinon 1
0.4%
phoroglucinol 1
0.4%
phoroglucinol cp 1
0.4%
ploroglucinol 1
0.4%
profundin 1
0.4%
provera 2
0.9%
quinine 4
1.8%
quinine 300 2
0.9%
vitamine c 1
0.4%
xylocaine 1
0.4%
zinnia 1
0.4%
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Back to Catalog
IHSN Survey Catalog

© IHSN Survey Catalog, All Rights Reserved.